Preparation method of ganoderma lucidum spore powder chewable tablets
Through the combination of broken wall Ganoderma lucidum spore powder, fruit powder, calcium hydrogen phosphate and vitamin D3, the taste, solubility and molding of Ganoderma lucidum spore powder is solved, and the good molding and calcium supplement of chewable tablets are achieved, which improves its bioavailability and Nutritional value.
Patent Information
- Application Number
- CN202311341108.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-17
- Publication Date
- 2024-11-08
AI Technical Summary
Ganoderma lucidum spore powder has problems such as poor taste, poor solubility, poor digestion and absorption, and difficulty in tableting forming in applications, and lacks calcium supplementation functions, which limits its promotion in health foods.
Use the combination of broken wall Ganoderma lucidum spore powder with fruit powder, calcium biphosphate, vitamin D3, etc. to improve the taste through fruit powder and flavoring agents, use the oil absorption characteristics of calcium biphosphate and vitamin D3 to promote calcium absorption, and combine microcrystalline cellulose and stearic acid. Magnesium is used to form tablets.
It improves the taste and solubility of Ganoderma lucidum spore powder, enhances its bioavailability, achieves good molding and calcium supplementation effects of chewable tablets, provides a variety of bioactive ingredients, and enhances the nutritional value and health benefits of the product.
Smart Images

Figure CN118902073A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of health food and relates to a method for preparing a ganoderma lucidum spore powder chewable tablet. Background Art
[0002] Ganoderma lucidum spore powder is Ganoderma lucidum ( Ganoderma lucidum ) The extremely tiny oval reproductive cells ejected from the gills of Ganoderma lucidum during the powdering period are the seeds of Ganoderma lucidum. It has a variety of active ingredients, such as polysaccharides, triterpenes, soluble proteins, amino acids, alkaloids and nucleosides. These diverse ingredients give Ganoderma lucidum spore powder important functions in preventing and treating a variety of health problems, such as cardiovascular disease, liver cirrhosis, anti-tumor, immunomodulation, anti-aging and antibacterial. However, despite the many medicinal values of Ganoderma lucidum spore powder, its application is subject to some restrictions, such as the following aspects: (1) Taste problem: Ganoderma lucidum spore powder is tasteless and light in texture, which makes it difficult for general consumers to accept, especially the elderly.
[0003] (2) Solubility problem: Ganoderma lucidum spore powder is not easy to dissolve, is easy to stick to the wall, and the overall sensory perception is poor.
[0004] (3) Digestion and absorption problems: Ganoderma lucidum spore powder is surrounded by hard chitinous cellulose, which is difficult for the human body to absorb and utilize.
[0005] (4) Tablet pressing problem: Some oily components and plant fiber components in Ganoderma lucidum spore powder are not conducive to tablet pressing, and the tablets have a bitter taste after pressing.
[0006] These problems have not been fully solved, and only one or two aspects can be solved. Zhang Jian et al. (Zhang Jian, Gong Zhiqing, Cui Wenjia, et al. Optimization of the formulation of Ganoderma lucidum spore powder tablets based on the Box-Behnken method [J]. Food Industry, 2021, 42(11): 6-10.) mixed Ganoderma lucidum spore powder with a natural sweetener (rose powder) based on the Box-Behnken method to improve its taste. Peng Wen et al. (Peng Wen, Liu Wenjie, Zeng Li, et al. Study on the dissolution rate of Ganoderma lucidum spore powder polysaccharides in artificial gastrointestinal fluid [J]. Food Industry, 2008(04): 14-16.) found that the wall-breaking treatment of Ganoderma lucidum spores is conducive to the release of its effective ingredients in the human gastrointestinal tract, thereby improving its bioavailability in the gastrointestinal tract. In addition, in a patent for a broken wall Ganoderma lucidum spore powder tablet (a broken wall Ganoderma lucidum spore powder tablet and its preparation method [P]. Zhejiang Province: CN115918900A, 2023-04-07.), it is proposed to use a combination of sorbitol and silicon dioxide to enhance the compressibility of broken wall Ganoderma lucidum spore powder. Although these methods and studies provide useful insights and solutions to overcome the application problems of Ganoderma lucidum spore powder, each method has its specific advantages and limitations. Therefore, it is difficult to meet the specific requirements of the product, and a more comprehensive solution needs to be sought.
[0007] Calcium, as a key mineral required by the human body, is essential for maintaining the health of bones, cardiovascular and nervous systems. Calcium deficiency may lead to bone diseases, as well as other health problems. However, there are no reports on compounding calcium hydrogen phosphate with vitamin D3 and Ganoderma lucidum spore powder. Therefore, how to optimize the formula to improve the product's taste, solubility, digestion and absorption, and tablet forming, and at the same time develop a Ganoderma lucidum spore powder chewable tablet with good taste and certain calcium supplementation effect will become a technical problem that technicians in this field need to solve urgently. The solution to this technical problem will enable the product to provide more nutritional value and health benefits, be more acceptable, and promote the promotion and application of Ganoderma lucidum spore powder. Summary of the invention
[0008] In view of the shortcomings of the prior art, the present invention aims to provide a method for preparing a Ganoderma lucidum spore powder chewable tablet.
[0009] The present invention uses broken wall ganoderma lucidum spore powder as the main material, and uses fruit powder, calcium hydrogen phosphate and other tablet auxiliary materials to assist in tableting. First, the taste problem of ganoderma lucidum spore powder is solved by combining fruit powder and flavor correctives; second, the oil absorption property of calcium hydrogen phosphate is fully utilized and it is also used as a source of calcium supplement, solving the problem of difficulty in tableting ganoderma lucidum spore powder; third, an appropriate amount of vitamin D3 is added in combination with calcium hydrogen phosphate to promote the absorption of calcium by the human body, so that the nutrition and efficacy of the chewable tablet are stronger.
[0010] To achieve the above-mentioned purpose, the present invention adopts the following technical scheme: a method for preparing a chewable tablet of Ganoderma lucidum spore powder, comprising the following components by weight: 16.6-33.3 g of broken-wall Ganoderma lucidum spore powder, 16-34 g of calcium hydrogen phosphate, 6-10 g of fruit powder, 20-30 g of 60% monosaccharide syrup, 0.2-0.6 g of magnesium stearate, 12.5-20.8 g of microcrystalline cellulose, 0.08-0.42 g of saccharin sodium and 0.002-0.004 g of vitamin D3.
[0011] Preferably, in the chewable tablet, the wall-breaking rate of the Ganoderma lucidum spore powder is ≥ 98%.
[0012] Preferably, in the chewable tablet, the fruit powder is mango powder.
[0013] More preferably, the chewable tablet is composed of the following components by weight: 25 g of broken wall Ganoderma lucidum spore powder, 25 g of calcium hydrogen phosphate, 8.3 g of mango powder, 25 g of 60% monosaccharide syrup, 0.42 g of magnesium stearate, 16.7 g of microcrystalline cellulose, 0.25 g of saccharin sodium, and 0.003 g of vitamin D3.
[0014] Furthermore, the chewing comprises the following preparation steps: (1) Pretreatment: screening and drying of raw materials for later use; (2) Premixing: Premix the weighed broken wall Ganoderma lucidum spore powder, mango powder and calcium hydrogen phosphate in proportion by weight; (3) Adding excipients: Add microcrystalline cellulose, saccharin sodium and vitamin D3 to the premixed materials and mix thoroughly. Then add an appropriate amount of 60% monosaccharide syrup and mix well to make a soft material. Disperse it into small wet granules that can be kneaded and pressed, and granulate it through a 16-20 mesh sieve. (4) Drying: After granulation, place the granules in an oven at 50-60°C for 30 min to spread the wet granules evenly on the tray to prevent sticking and uneven drying. (5) Total mixing: After drying, sieve through a 16-20 mesh sieve, add magnesium stearate and mix for 5-10 minutes; (6) Tablet pressing: Tablet hardness is controlled at 40-50 N.
[0015] The pretreatment in step (1) further comprises the following steps: (1) Preparing Ganoderma lucidum spore powder: the broken Ganoderma lucidum spore powder is passed through a 100-mesh sieve and then dried at 60°C to constant weight; (2) Prepare fruit powder: crush or grind dried mango, pass through a 100-mesh sieve, and dry at 60°C until constant weight; (3) Prepare additives: Pass all the auxiliary materials required for tableting through a 100-mesh sieve for later use; (4) Prepare 60% monosaccharide syrup: Weigh an appropriate amount of sucrose powder and heat it at 60°C to dissolve it into a monosaccharide syrup solution with a weight ratio of 60%.
[0016] The advantages of the present invention can be summarized as follows: Excellent taste: The Ganoderma lucidum spore powder chewable tablets of the present invention have been optimized in formula, and have overcome the characteristics of being tasteless and easy to float away of traditional Ganoderma lucidum spore powder tablets, and have excellent taste, and are more easily accepted by consumers.
[0017] Calcium supplementation effect: The chewable tablet of the present invention has calcium hydrogen phosphate added to its formula, which can effectively supplement the daily calcium needs of the human body. In addition, the oil absorption property of calcium hydrogen phosphate makes the chewable tablet easier to shape.
[0018] Diversified nutrients: The ganoderma lucidum spore powder and mango powder added in the present invention are both rich in multiple active ingredients. Among them, the spore powder contains important ingredients such as polysaccharides and triterpenoid compounds, while the mango powder is rich in mangophenol, mangiferin and multiple natural antioxidants, such as vitamin C and vitamin A. These rich and diverse ingredients give the chewable tablets multiple biological activities, making it a high-value nutritional supplement.
[0019] Convenient oral form: Chewable tablets are accurate in dosage, easy to carry and use, and expand the age group.
[0020] Good digestion and absorption: The present invention preferably uses Ganoderma lucidum spore powder with a wall-breaking rate of ≥98% as raw material, which makes it easier for the human body to digest and absorb. The increased dissolution rate of polysaccharides and triterpenes improves the bioavailability of the Ganoderma lucidum spore powder, thereby improving the efficacy of the chewable tablets.
[0021] In summary, the Ganoderma lucidum spore powder chewable tablets of the present invention have the advantages of improving taste and supplementing calcium while having multiple biological activities, providing consumers with a convenient, delicious and healthy product choice, and will be widely used in the field of health care products. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 Glucose standard curve; Figure 2 is the standard curve of oleanolic acid; Figure 3 is the effect of different fruit powders on the sensory evaluation scores of chewable tablets; Figure 4 The effects of (a) calcium hydrogen phosphate, (b) 60% monosaccharide syrup, (c) magnesium stearate, and (d) sodium saccharin addition on sensory evaluation; Figure 5 This is a 3D response surface diagram, (a) 60% monosaccharide syrup and magnesium stearate; (b) 60% monosaccharide syrup and sodium saccharin; (c) 60% monosaccharide syrup and calcium hydrogen phosphate; (d) sodium saccharin and magnesium stearate; (e) magnesium stearate and calcium hydrogen phosphate; (f) sodium saccharin and calcium hydrogen phosphate. Implementation
[0023] The present invention is described in further detail below.
[0024] Implementation Plan 1 Quality Inspection Index and Method for Broken-wall Ganoderma Lucidum Spore Powder
[0025] (1) Determination of polysaccharide content Refer to the determination method of Ganoderma lucidum polysaccharide content in the Appendix of the first medicinal materials and decoction pieces of the 2020 edition of the Chinese Pharmacopoeia. Draw a standard curve with different concentrations of anhydrous glucose. The results are as follows Figure 1 The polysaccharide content was calculated to be 1.23±0.15%, which meets the requirement of ≥0.9% in the pharmacopoeia.
[0026] (2) Determination of triterpene content The same as above refers to the 2020 edition of the Chinese Pharmacopoeia. A standard curve was drawn with different concentrations of oleanolic acid solution. The results are as follows Figure 2 The triterpene content was calculated to be 1.85±0.13%, which was in line with the requirement of ≥0.5% in the pharmacopoeia.
[0027] (3) Determination of wall breaking rate Refer to the determination method of the breaking rate of broken wall Ganoderma lucidum spores in the "Technical Requirements for Health Food Products" issued by the State Food and Drug Administration. Take appropriate amounts of unbroken wall Ganoderma lucidum spore powder and broken wall Ganoderma lucidum spore powder from the same batch and dry them in an oven at 60°C for 5 h. Accurately weigh 0.1000 g of dried unbroken wall spore powder and 0.1500 g of broken wall spore powder. Then weigh 5.0 g of sucrose powder that has been ground and passed through a 100-mesh sieve, and mix them with the two spores until the color is uniform. Dissolve the above samples in distilled water, add 0.1 mL of Tween 80 to the sample solution, dilute to a 100 mL volumetric flask with distilled water, and ultrasonically shake at room temperature for 30 min to fully disperse the spores. Then drop it on a hemocytometer and place it under an optical microscope with a magnification of 200 times or more for observation and counting. It is calculated that the breaking rate of Ganoderma lucidum spore powder is ≥98%.
[0028] Implementation Plan 2: Preparation Process of Ganoderma Lucidum Spore Powder Chewable Tablets (1) Pretreatment: All raw materials and auxiliary materials are sieved through a 100-mesh sieve. Ganoderma lucidum spore powder and mango powder are dried at 60°C to constant weight to ensure that the moisture content is less than 8%; (2) Premixing: Premix the weighed broken wall Ganoderma lucidum spore powder, mango powder and calcium hydrogen phosphate in proportion by weight; (3) Adding excipients: Add microcrystalline cellulose, saccharin sodium and vitamin D3 to the premixed materials and mix thoroughly. Then add an appropriate amount of 60% monosaccharide syrup and mix well to make a soft material. Disperse it into small wet granules that can be kneaded and pressed, and then sieve through a 16-20 mesh sieve for granulation. (4) Drying: After granulation, place the granules in an oven at 50-60°C for 30 min to spread the wet granules evenly on the tray to prevent sticking and uneven drying. (5) Total mixing: After drying, sieve through a 16-20 mesh sieve, add magnesium stearate and mix for 5-10 min; (6) Tablet pressing: The tablet hardness is controlled at 40-50 N.
[0029] Implementation Plan 3: Formulation Screening
[0030] The present invention is a chewable tablet of ganoderma lucidum spore powder containing calcium hydrogen phosphate and vitamin D3, and the following aspects are considered in the formula design: 1) the source of auxiliary materials is easy to obtain; 2) the prepared particles have good fluidity and oil absorption, and are easy to tablet; 3) the taste is good when chewing; 4) the calcium supplement effect. After screening, fruit powder and saccharin sodium are selected as flavoring agents based on taste considerations, 60% monosaccharide syrup is selected as a binder, calcium hydrogen phosphate and microcrystalline cellulose are selected as fillers based on oil absorption and calcium supplementation considerations, and an appropriate amount of vitamin D3 is used as a nutrient supplement to promote calcium absorption, and magnesium stearate is used as a lubricant.
[0031] Implementation Plan 4: Selection of inspection indicators and determination of weight coefficients
[0032] The appearance, texture, color, flavor and taste of the Ganoderma lucidum spore powder chewable tablets were subjected to sensory evaluation. Table 1 shows the specific sensory evaluation standards for the Ganoderma lucidum spore powder chewable tablets.
[0033]
[0034] Implementation Plan 5: Selection of Fruit Powder
[0035] Strawberry powder, mango powder, blueberry powder and mint powder were mixed with Ganoderma lucidum spore powder respectively, and the sensory evaluation score was used as the evaluation index for selection. The scoring results are as follows Figure 3 As shown. It was found that when the four kinds of fruit powders were combined with Ganoderma lucidum spore powder, the scores obtained were 57 points for strawberry powder, 78 points for mango powder, 75 points for blueberry powder, and 70 points for mint powder. Among them, the chewable tablets prepared by combining mango powder and Ganoderma lucidum spore powder had good shape, good flavor, and the highest sensory evaluation score. Therefore, mango powder was selected as the raw material for Ganoderma lucidum spore powder chewable tablets.
[0036] Implementation Plan 6 Single Factor Design of Chewable Tablet Excipients
[0037] A single factor experiment was conducted on the addition of calcium hydrogen phosphate, sodium saccharin, 60% monosaccharide syrup and magnesium stearate in the chewable tablet formula. The optimal solution for the formula of Ganoderma lucidum spore powder chewable tablets was explored based on the sensory evaluation score of the tablets. The results are as follows: Figure 4 shown.
[0038] (1) Determination of the amount of calcium hydrogen phosphate added Ganoderma lucidum spore powder chewable tablets require two types of fillers, normal water-soluble excipients and inorganic salts. The main function of calcium salts is to absorb the oily components in the spores and supplement calcium, reducing the impact of spore oil on tablet quality. Under the conditions of fixed Ganoderma lucidum spore powder addition of 3 g, mango powder addition of 1 g, microcrystalline cellulose addition of 2 g, saccharin sodium addition of 0.05 g, magnesium stearate addition of 0.05 g, monosyrup addition of 3 g, and vitamin D3 addition of 0.00036 g, the effect of calcium hydrogen phosphate addition of 2 g, 3 g, and 4 g on the sensory quality of chewable tablets was investigated (the above raw materials were weighed based on weight components and 100 g).
[0039] The results showed that the score of the chewable tablets increased slowly with the increase of calcium hydrogen phosphate, reaching 70 points when adding 2 g, and reaching the highest point of 73 points when adding 3 g. In this case, the chewable tablets had a smooth surface and no oil spots. Then, the sensory evaluation dropped rapidly to 58 points when the addition of calcium hydrogen phosphate continued to increase. Therefore, 3 g of calcium hydrogen phosphate was selected as the optimal addition amount for the chewable tablets of Ganoderma lucidum spore powder.
[0040] (2) Determination of the amount of saccharin sodium added Under the conditions of fixed addition amount of Ganoderma lucidum spore powder at 3 g, mango powder at 1 g, microcrystalline cellulose at 2 g, calcium hydrogen phosphate at 3 g, magnesium stearate at 0.05 g, monosaccharide at 3 g and vitamin D3 at 0.00036 g, the effect of adding 0.01 g, 0.03 g and 0.05 g of saccharin sodium on the sensory quality of chewable tablets was investigated (all the above raw materials were weighed based on 100 g of weight components).
[0041] The results showed that the sensory scores obtained from low to high addition of saccharin sodium were 58, 75, and 69, respectively. When 0.03 g was added, the sensory score reached the highest point of 75 points. In this case, the chewable tablets had a smooth taste without the bitter taste unique to Ganoderma lucidum spore powder. Then, as the addition of saccharin sodium continued to increase, the sensory evaluation score began to decrease to 69 points. Therefore, 0.03 g of saccharin sodium was selected as the optimal addition amount of Ganoderma lucidum spore powder chewable tablets.
[0042] (3) Determination of the amount of 60% monosaccharide syrup added Under the conditions of fixed addition amount of Ganoderma lucidum spore powder at 3 g, mango powder at 1 g, microcrystalline cellulose at 2 g, calcium hydrogen phosphate at 3 g, magnesium stearate at 0.05 g, saccharin sodium at 0.05 g and vitamin D3 at 0.00036 g, the effect of adding 2.5 g, 3 g and 3.5 g of monosyrup on the sensory quality of chewable tablets was investigated (all the above raw materials were weighed based on 100 g of weight components).
[0043] The results showed that the sensory scores obtained from low to high addition amounts of 60% monosaccharide syrup were 62, 70 and 65 points respectively, among which the highest sensory score reached 70 points when 3 g was added. Therefore, 3 g of 60% monosaccharide syrup was selected as the optimal addition amount of Ganoderma lucidum spore powder chewable tablets.
[0044] (4) Determination of the amount of magnesium stearate added The addition of lubricant can increase the compressibility of tableting particles. If too little or no lubricant is added, the particles may have poor fluidity, tableting is laborious, and tableting is sticky; too much will make the tablets too thin or softened. The present invention uses the most commonly used hydrophobic lubricant magnesium stearate, and explores the effects of magnesium stearate additions of 0.03, 0.05, and 0.07 on the sensory quality of chewable tablets under the conditions of fixed additions of 3 g of Ganoderma lucidum spore powder, 1 g of mango powder, 2 g of microcrystalline cellulose, 3 g of calcium hydrogen phosphate, 3 g of 60% monosaccharide syrup, 0.05 g of saccharin sodium, and 0.00036 g of vitamin D3 (the above raw materials are all weighed based on weight components and 100 g).
[0045] The results showed that as the amount of magnesium stearate added increased, the overall sensory evaluation of the tablets increased, reaching a peak at 0.05 g. After further increase, the sensory evaluation score began to decrease, and the specific sensory scores were 74, 84, and 69, respectively, from low to high according to the amount of addition. Therefore, 0.05 g of magnesium stearate was selected as the optimal amount of Ganoderma lucidum spore powder chewable tablets.
[0046] Implementation Plan 7: Response Surface Experimental Design to Explore the Optimal Formula of Chewable Tablets
[0047] On the basis of the single factor experiment, the response surface design was carried out using the statistical analysis software Design-Expert V 8.0.6, with 60% monosyrup, magnesium stearate, sodium saccharin and calcium hydrogen phosphate added as test factors and sensory evaluation scores as response values, as shown in Table 2.
[0048]
[0049] Table 3 Response surface experiment scheme and results Experiment number 60% simple syrup / g Magnesium stearate / g Saccharin sodium / g Calcium hydrogen phosphate / g Sensory evaluation 1 2.5 0.05 0.05 3.0 68 2 3.5 0.07 0.03 3.0 79 3 3.0 0.07 0.03 4.0 68 4 2.5 0.05 0.01 3.0 76 5 3.5 0.05 0.05 3.0 79 6 3.0 0.07 0.01 3.0 74 7 3.0 0.05 0.05 4.0 73 8 2.5 0.05 0.03 2.0 69 9 3.0 0.03 0.01 3.0 76 10 3.0 0.03 0.05 3.0 77 11 3.5 0.03 0.03 3.0 76 12 2.5 0.05 0.03 4.0 67 13 3.0 0.05 0.03 3.0 85 14 2.5 0.03 0.03 3.0 76 15 3.0 0.05 0.03 3.0 84 16 3.0 0.05 0.01 2.0 74 17 3.0 0.05 0.01 4.0 69 18 3.0 0.05 0.03 3.0 86 19 3.0 0.05 0.03 3.0 86 20 3.5 0.05 0.03 4.0 70 21 3.5 0.05 0.03 2.0 73 22 3.0 0.05 0.05 2.0 78 23 3.0 0.03 0.03 4.0 75 24 3.0 0.07 0.03 2.0 74 25 3.0 0.07 0.05 3.0 74 26 3.0 0.03 0.03 2.0 74 27 3.5 0.05 0.01 3.0 75 28 2.5 0.07 0.03 3.0 70 29 3.0 0.05 0.03 3.0 87 Table 4 Analysis of variance of response surface model Source Sum of Squares df Mean Square -value -value Model 858.08 14 61.29 19.09 <0.0001 A-60% simple syrup 56.33 1 56.33 17.55 0.0009 B-Magnesium Stearate 18.75 1 18.75 5.84 0.0299 C-Saccharin Sodium 2.08 1 2.08 0.65 0.4340 D-Calcium Hydrogen Phosphate 33.33 1 33.33 10.38 0.0061 AB 20.25 1 20.25 6.31 0.0249 AC 36.00 1 36.00 11.21 0.0048 AD 0.25 1 0.25 0.078 0.7843 BC 0.25 1 0.25 0.078 0.7843 BD 12.25 1 12.25 3.82 0.0711 CD -1.137E-013 1 -1.137E-013 -3.541E-014 1.0000 <![CDATA[A 2 ]]> 278.29 1 278.29 86.67 <0.0001 <![CDATA[B 2 ]]> 141.77 1 141.77 44.15 <0.0001 <![CDATA[C 2 ]]> 141.77 1 141.77 44.15 <0.0001 <![CDATA[D 2 ]]> 446.85 1 446.85 139.18 <0.0001 Residual 44.95 14 3.21 Lack of Fit 39.75 10 3.98 3.06 0.1464 error 5.20 4 1.30 Total variables 903.03 28 Model determination coefficient R-Squared 0.9502 Model adjustment confirmed Adj R-Squared 0.9004 CV% 2.37 Precision Adeq 14.304
[0050] The quadratic regression equation of the sensory evaluation of Ganoderma lucidum spore powder chewable tablets with four factors including 60% monosaccharide syrup (A), magnesium stearate (B), sodium saccharin (C) and calcium hydrogen phosphate (D) was obtained by using Design-Expert V 8.0.6 software: Y=85.6+2.17A-1.25B+0.42C-1.67D+2.25AB+3AC-0.25AD-0.25BC-1.75BD+0.000CD-6.55A 2 -4.67B 2- 4.67C 2 -8.30D 2
[0051] The model in Table 3 was subjected to variance analysis, and the results are shown in Table 4. P The value is less than 0.0001, indicating that the model has reached an extremely significant level; the results of variance analysis show that the precision of the model is 14.304, R 2 is 0.9502, indicating that the model has a high degree of fit and a small error. 95.02% of the data are relatively reasonable. Therefore, the model is suitable for analyzing and predicting the effects of four excipients in Ganoderma lucidum spore powder chewable tablets on sensory evaluation. The response surface is shown in Figure 5 shown.
[0052] The optimal addition amount of four excipients in the Ganoderma lucidum spore powder chewable tablets was obtained through regression model analysis as 3 g of calcium hydrogen phosphate, 3 g of monosaccharide syrup, 0.05 g of magnesium stearate, and 0.03 g of saccharin sodium. In order to facilitate actual production operation, the optimal formula was revised to 3 g of Ganoderma lucidum spore powder, 1 g of fruit powder, 3 g of 60% monosaccharide syrup, 3 g of calcium hydrogen phosphate, 0.05 g of magnesium stearate, 2 g of microcrystalline cellulose, 0.03 g of saccharin sodium, and 0.00036 g of vitamin D3.
[0053] Implementation Plan 8 Chewable Tablet Quality Inspection Index and Method
[0054] (1) Moisture content detection: Determine according to the method in Part IV 0832 Moisture Determination Method of the 2020 Edition of the Chinese Pharmacopoeia. Weigh 2-5 g of the crushed Ganoderma lucidum spore powder chewable tablets, and then spread them evenly in a constant weight weighing bottle to make the thickness less than 5 mm. Then accurately weigh it with an analytical balance, do not cover the bottle cap, and dry it in an oven at 100-105°C. After 5 hours, take it out and cover the bottle cap, move it to a desiccator and store it for 30 minutes to cool it to room temperature. Weigh it again with an analytical balance, dry it in an oven for 1 hour, cool it down for 30 minutes, and accurately weigh it until the difference with the previous weighing result is no more than 5 mg. The weight that is reduced compared with the initial weight is the moisture content (%) contained in the test sample particles.
[0055] The moisture content determination results are shown in Table 5. It can be seen from the table that the moisture content of the three batches is less than the limit of 8%, which meets the requirements.
[0056]
[0057] (2) Tablet weight difference: This was conducted according to the weight difference inspection method under Item 0101 Tablets in Part III of the 2020 edition of the Chinese Pharmacopoeia. The results showed that the average tablet weight of batch 1 was 0.4271 g, the average tablet weight of batch 2 was 0.4273 g, and the average tablet weight of batch 3 was 0.4262 g. Based on the data of the three batches, it can be seen that the weight differences of the three batches all met the requirements.
[0058] (3) Hardness test: Three tablets were randomly selected from three batches of Ganoderma lucidum chewable tablets, placed in the SY-2D tablet four-in-one tester, and the hardness values were recorded. The results are shown in Table 6. The average hardness value of the chewable tablets of the three batches was 45 N, which was moderate in hardness and could be stored and transported in a normal manner and was easy to chew.
[0059] Table 6 Hardness inspection table Hardness / N Test results Standard value No debris when falling from 1.5 m qualified Batch 1 49.83 qualified Batch 2 43.73 qualified Batch 3 42.56 qualified (4) Friability: Randomly select appropriate amounts of Ganoderma lucidum spore powder chewable tablets from three batches, first remove the fine powder on the surface of the Ganoderma lucidum spore powder chewable tablets, then accurately weigh about 6.5 g of the chewable tablets using an analytical balance, place them in a SY-2D tablet four-in-one measuring instrument, set the speed and time, rotate 100 times, take out and remove the surface powder again in the same way, accurately weigh the mass using an analytical balance, and use the calculated reduction percentage to express the friability. The results are shown in Table 7 below.
[0060] Table 7 Friability inspection table Initial value / g End value / g Friability / % Test results 6.693 6.64 0.79 qualified (5) Heavy metals: The heavy metals were determined according to the corresponding heavy metal determination method in Section 2321 of Part IV of the 2020 edition of the Chinese Pharmacopoeia. The results are shown in Table 8. As can be seen from the table, the contents of chromium, copper, zinc, arsenic, lead and cadmium in the Ganoderma lucidum spore powder chewable tablets all meet the limit requirements for the content of each heavy metal under the enterprise standard Q / YBZ0001-2017.
[0061] Table 8 Heavy metal content of chewable tablets heavy metal Physical and chemical indicators (mg / kg) Chewable tablet (mg / kg) Chromium (Cr) ≤0.5 0.20 Copper (Cu) ≤5.0 0.33 Zinc (Zn) ≤5.0 0.35 Arsenic (As) ≤1.0 <![CDATA[<10 -5 ]]> Lead (Pb) ≤0.5 <![CDATA[<2×10 -5 ]]> Cadmium (Pd) ≤0.1 <![CDATA[<10 -6 ]]> Based on the above results, the tested chewable tablets meet the relevant quality standards in terms of moisture content, tablet weight, hardness, friability and heavy metal content.
[0062] The present invention has been described in further detail above. The above description is only a preferred embodiment of the present invention and should not limit the scope of implementation of the present invention. That is, all equivalent changes and modifications made within the scope of this application should still fall within the scope of the present invention.
Claims
1. A method for preparing a chewable tablet of Ganoderma lucidum spore powder, characterized in that: The chewable tablet comprises the following components by weight (based on 100 g): 16.6-33.3 g of broken wall ganoderma spore powder, 16-34 g of calcium hydrogen phosphate, 6-10 g of mango powder, 20-30 g of 60% simple syrup, 0.2-0.6 g of magnesium stearate, 12.5-20.8 g of microcrystalline cellulose, 0.08-0.42 g of saccharin sodium and a trace amount of 0.002-0.004 g of vitamin D3.
2. The chewable tablet according to claim 1, characterized in that: The optimal weight components of the chewable tablet are 25 g of broken wall Ganoderma lucidum spore powder, 25 g of calcium hydrogen phosphate, 8.3 g of mango powder, 25 g of 60% simple syrup, 0.42 g of magnesium stearate, 16.7 g of microcrystalline cellulose, 0.25 g of saccharin sodium, and 0.003 g of vitamin D3.
3. The chewable tablet according to claim 1, characterized in that: The wall breaking rate of Ganoderma lucidum spore powder is ≥98%, the dried mango is crushed or ground and passed through a 100-mesh sieve, and the remaining additives of calcium hydrogen phosphate, magnesium stearate, microcrystalline cellulose, saccharin sodium, and vitamin D3 (100,000 IU / g) are commercially available food grade.
4. The chewable tablet according to claim 1, characterized in that: The mango powder and sodium saccharin are flavoring agents; the 60% simple syrup is a binder; the microcrystalline cellulose and calcium hydrogen phosphate are fillers, and the calcium hydrogen phosphate also serves as an oil absorbent and calcium supplement; the magnesium stearate is a lubricant; and the vitamin D3 is a supplementary nutrient.
5. The chewable tablet according to claim 1, comprising the following preparation steps: (1) pretreatment: sieving and drying the raw materials for later use; (2) premixing: premixing the weighed broken wall ganoderma spore powder, mango powder and calcium hydrogen phosphate in proportion by weight; (3) adding excipients: adding microcrystalline cellulose, sodium saccharin and vitamin D3 to the premixed materials and mixing them thoroughly, then adding an appropriate amount of 60% monosaccharide syrup and mixing them to make a soft material, so that the premixed materials are dispersed into fine wet granules that can be kneaded into a ball and pressed and then granulated through a 16-20 mesh sieve; (4) drying: after granulation, drying in an oven at 50-60°C for 30 min, so that the wet granules are evenly spread on the tray to prevent sticking and uneven drying; (5) total mixing: after drying, sieve the granules through a 16-20 mesh sieve, add magnesium stearate and mix for 5-10 min; (6) tableting: the tablet hardness is controlled at 40-50 N.
6. The process for preparing a chewable tablet according to claim 5, characterized in that: The pretreatment in step (1) specifically includes the following steps: 1) preparing ganoderma lucidum spore powder: the wall-broken ganoderma lucidum spore powder is passed through a 100-mesh sieve and then dried at 60°C to constant weight; 2) preparing fruit powder: dried mango is crushed or ground and then passed through a 100-mesh sieve and then dried at 60°C to constant weight; 3) preparing additives: all auxiliary materials required for tableting are passed through a 100-mesh sieve for later use; 4) preparing 60% monosaccharide syrup: an appropriate amount of sucrose powder is weighed and heated at 60°C to dissolve to prepare a monosaccharide syrup solution with a weight ratio of 60%.
